Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded
- Contract number
- SPE2DB26FD1BB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,005
Award facts
- Contract value 100% obligated
- $7,005.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $7,005.39 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of TYMLOS 80 MCG Dose Pen Injectr 1.56ML. This delivery order, issued on October 17, 2025, with an ultimate completion date of October 20, 2025, carries no set-aside designation and represents a standard competitive award under DMS Pharmaceutical Group's existing indefinite delivery contract. The company will perform the work at its Park Ridge, Illinois location.
This award falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The underlying $499.9 billion master contract, awarded November 13, 2025, with completion through December 31, 2036, establishes DMS Pharmaceutical Group as a regional prime vendor contractor supporting Department of Defense pharmaceutical supply needs globally. The company's extensive product portfolio includes branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, positioning it as a critical supplier within the federal military medical supply chain. This delivery order exemplifies the routine pharmaceutical procurement executed under the broader PPV-G GEN V acquisition strategy to sustain recurring medical supply requirements across military healthcare facilities.
Quick answers
Who was awarded contract SPE2DB26FD1BB?
SPE2DB26FD1BB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FD1BB worth?
The government has obligated $7,005 on SPE2DB26FD1BB.
Is contract SPE2DB26FD1BB an order under another contract?
Yes. SPE2DB26FD1BB is a delivery order under SPE2DB20D9226, an indefinite delivery contract.
Was contract SPE2DB26FD1BB competed?
The extent of competition for SPE2DB26FD1BB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award